Last 12 months
Inside the activity.
10 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 2 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 6 | 2 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 2 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 27, 2021 Filed Apr 29, 2021 21:46 UTC |
Dawson Michael JohnChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 2,800 | Not disclosed Strike: $26.85 | Not disclosed |
DisclosureSEC source: 0001209191-21-029066 · doc4.xml · derivative · entry 5 Dawson Michael John · CIK 0001849790 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,800 Underlying: Common Stock · 2,800 shares Expires 2030-02-19 F8 · price: Received in the Merger in exchange for a stock option to acquire 103,000 shares of LBS common stock for $0.73 per share. F1 · derivative.exercise_date: The stock option vested in four equal quarterly installments from the vesting commencement date. Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 21:46 UTC |
Dawson Michael JohnChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 1,962 | Not disclosed Strike: $41.20 | Not disclosed |
DisclosureSEC source: 0001209191-21-029066 · doc4.xml · derivative · entry 4 Dawson Michael John · CIK 0001849790 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,962 Underlying: Common Stock · 1,962 shares Expires 2029-03-22 F7 · price: Received in the Merger in exchange for a stock option to acquire 72,200 shares of LBS common stock for $1.12 per share. F1 · derivative.exercise_date: The stock option vested in four equal quarterly installments from the vesting commencement date. Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 21:46 UTC |
Dawson Michael JohnChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 5,084 | Not disclosed Strike: $41.20 | Not disclosed |
DisclosureSEC source: 0001209191-21-029066 · doc4.xml · derivative · entry 3 Dawson Michael John · CIK 0001849790 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,084 Underlying: Common Stock · 5,084 shares Expires 2029-03-22 F6 · price: Received in the Merger in exchange for a stock option to acquire 187,000 shares of LBS common stock for $1.12 per share. F5 · derivative.exercise_date: The stock option vests according to the following schedule: 33% of the shares underlying the option vests on grant date and the remaining 67% vests in eight equal quarterly installments thereafter beginning on March 31, 2019. Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 21:46 UTC |
Dawson Michael JohnChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 20,391 | Not disclosed Strike: $53.33 | Not disclosed |
DisclosureSEC source: 0001209191-21-029066 · doc4.xml · derivative · entry 2 Dawson Michael John · CIK 0001849790 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,391 Underlying: Common Stock · 20,391 shares Expires 2028-07-24 F4 · price: Received in the Merger in exchange for a stock option to acquire 750,000 shares of LBS common stock for $1.45 per share. F3 · derivative.exercise_date: The stock option vests according to the following schedule: 17% of the shares underlying the option vests on grant date and the remaining 83% vests in 10 quarterly installments thereafter beginning on September 30, 2018. Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 21:46 UTC |
Dawson Michael JohnChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 5,438 | Not disclosed Strike: $27.59 | Not disclosed |
DisclosureSEC source: 0001209191-21-029066 · doc4.xml · derivative · entry 1 Dawson Michael John · CIK 0001849790 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,438 Underlying: Common Stock · 5,438 shares Expires 2027-02-10 F2 · price: Received in exchange for a stock option to acquire 200,000 shares of common stock of Leading BioSciences, Inc. ("LBS") for $0.75 per share, pursuant to the Agreement and Plan of Merger, dated December 16, 2020, among Seneca Biopharma Inc., Townsgate Acquisition Sub 1, Inc. and LBS (the "Merger"). Per the terms of the Merger, each share of LBS's common stock was converted into the right to receive 0.02719 shares of Seneca's common stock. In the Merger, the name of the Issuer was changed from Seneca Biopharma, Inc. to Palisade Bio, Inc. F1 · derivative.exercise_date: The stock option vested in four equal quarterly installments from the vesting commencement date. Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 21:54 UTC |
Neal James RDirector
|
GrantStock Option (Right to Buy) · Derivative | 4,406 | Not disclosed Strike: $26.85 | Not disclosed |
DisclosureSEC source: 0001209191-21-029078 · doc4.xml · derivative · entry 6 Neal James R · CIK 0001600865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,406 Underlying: Common Stock · 4,406 shares Expires 2030-07-10 F12 · price: Received in the Merger in exchange for a stock option to acquire 162,069 shares of LBS common stock for $0.73 per share. F11 · derivative.exercise_date: The stock option vests according to the following schedule: 25% of the shares underlying the option vests on the grant date and the remaining 75% vested in three equal quarterly installments thereafter beginning on September 30, 2020. Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 21:54 UTC |
Neal James RDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,298 | Not disclosed Strike: $41.20 | Not disclosed |
DisclosureSEC source: 0001209191-21-029078 · doc4.xml · derivative · entry 5 Neal James R · CIK 0001600865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,298 Underlying: Common Stock · 1,298 shares Expires 2029-06-19 F10 · price: Received in the Merger in exchange for a stock option to acquire 47,758 shares of LBS common stock for $1.12 per share. F9 · derivative.exercise_date: The stock option is fully vested. Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 21:54 UTC |
Neal James RDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,091 | Not disclosed Strike: $41.20 | Not disclosed |
DisclosureSEC source: 0001209191-21-029078 · doc4.xml · derivative · entry 4 Neal James R · CIK 0001600865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,091 Underlying: Common Stock · 5,091 shares Expires 2029-04-25 F8 · price: Received in the Merger in exchange for a stock option to acquire 187,250 shares of LBS common stock for $1.12 per share. F7 · derivative.exercise_date: The stock option vested according to the following schedule: 25% of the shares underlying the option vested on the grant date and the remaining 75% vested in three equal quarterly installments thereafter beginning on June 30, 2019. Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 21:54 UTC |
Neal James RDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,359 | Not disclosed Strike: $53.33 | Not disclosed |
DisclosureSEC source: 0001209191-21-029078 · doc4.xml · derivative · entry 3 Neal James R · CIK 0001600865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,359 Underlying: Common Stock · 1,359 shares Expires 2028-07-24 F6 · price: Received in the Merger in exchange for a stock option to acquire 50,000 shares of LBS common stock for $1.45 per share. F5 · derivative.exercise_date: The stock option vested according to the following schedule: 50% of the shares underlying the option vested on the grant date and the remaining 50% vested in two equal quarterly installments thereafter beginning on September 30, 2018. Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 21:54 UTC |
Neal James RDirector
|
GrantStock Option (Right to Buy) · Derivative | 3,398 | Not disclosed Strike: $53.33 | Not disclosed |
DisclosureSEC source: 0001209191-21-029078 · doc4.xml · derivative · entry 2 Neal James R · CIK 0001600865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,398 Underlying: Common Stock · 3,398 shares Expires 2028-04-05 F4 · price: Received in the Merger in exchange for a stock option to acquire 125,000 shares of LBS common stock for $1.45 per share. F3 · derivative.exercise_date: The stock option vested according to the following schedule: 25% of the shares underlying the option vested on the grant date and the remaining 75% vested in three equal quarterly installments thereafter beginning on June 30, 2018. Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 21:54 UTC |
Neal James RDirector
|
GrantStock Option (Right to Buy) · Derivative | 849 | Not disclosed Strike: $27.59 | Not disclosed |
DisclosureSEC source: 0001209191-21-029078 · doc4.xml · derivative · entry 1 Neal James R · CIK 0001600865 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 849 Underlying: Common Stock · 849 shares Expires 2027-11-10 F2 · price: Received in exchange for a stock option to acquire 31,250 shares of common stock of Leading BioSciences, Inc. ("LBS") for $0.75 per share, pursuant to the Agreement and Plan of Merger, dated December 16, 2020, among Seneca Biopharma Inc., Townsgate Acquisition Sub 1, Inc. and LBS (the "Merger"). Per the terms of the Merger, each share of LBS's common stock was converted into the right to receive 0.02719 shares of Seneca's common stock. In the Merger, the name of the Issuer was changed from Seneca Biopharma, Inc. to Palisade Bio, Inc. F1 · derivative.exercise_date: The stock option vested in four equal quarterly installments from the vesting commencement date. Read SEC document |
| April 01, 2021 Filed Apr 26, 2021 23:55 UTC |
Mazzo David JDirector
|
GrantRestricted Stock Units · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-21-002778 · ownership.xml · derivative · entry 1 Mazzo David J · CIK 0001334549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires not disclosed F1 · security: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22. F2 · security: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F1 · shares: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22. F2 · shares: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F1 · derivative.exercise_date: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22. F1 · derivative.expiration_date: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22. Read SEC document |
| April 01, 2021 Filed Apr 26, 2021 23:53 UTC |
GRAY MARY ANNDirector
|
GrantRestricted Stock Units · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-21-002777 · ownership.xml · derivative · entry 1 GRAY MARY ANN · CIK 0001261974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires not disclosed F1 · security: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22. F2 · security: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F1 · shares: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22. F2 · shares: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F1 · derivative.exercise_date: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22. F1 · derivative.expiration_date: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22. Read SEC document |
| April 01, 2021 Filed Apr 26, 2021 23:52 UTC |
Csimma CristinaDirector
|
GrantRestricted Stock Units · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-21-002776 · ownership.xml · derivative · entry 1 Csimma Cristina · CIK 0001501623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires not disclosed F1 · security: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22. F2 · security: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F1 · shares: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22. F2 · shares: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F1 · derivative.exercise_date: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22. F1 · derivative.expiration_date: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22. Read SEC document |
| April 01, 2021 Filed Apr 26, 2021 23:51 UTC |
Wei BinxianDirector
|
GrantRestricted Stock Units · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-21-002775 · ownership.xml · derivative · entry 1 Wei Binxian · CIK 0001773586 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires not disclosed F1 · security: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22. F2 · security: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F1 · shares: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22. F2 · shares: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F1 · derivative.exercise_date: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22. F1 · derivative.expiration_date: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22. Read SEC document |
| April 03, 2020 Filed Apr 7, 2020 21:32 UTC |
Csimma CristinaDirector
|
GrantRestricted Stock Units · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-20-002464 · ownership.xml · derivative · entry 1 Csimma Cristina · CIK 0001501623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires not disclosed F1 · security: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21. F2 · security: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F1 · shares: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21. F2 · shares: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F1 · derivative.exercise_date: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21. F3 · derivative.expiration_date: N/A Read SEC document |
| April 03, 2020 Filed Apr 7, 2020 21:49 UTC |
Wei BinxianDirector
|
GrantRestricted Stock Units · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-20-002465 · ownership.xml · derivative · entry 1 Wei Binxian · CIK 0001773586 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires not disclosed F1 · security: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21. F2 · security: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F1 · shares: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21. F2 · shares: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F1 · derivative.exercise_date: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21. F3 · derivative.expiration_date: N/A Read SEC document |
| April 03, 2020 Filed Apr 7, 2020 21:31 UTC |
GRAY MARY ANNDirector
|
GrantRestricted Stock Units · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-20-002463 · ownership.xml · derivative · entry 1 GRAY MARY ANN · CIK 0001261974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires not disclosed F1 · security: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21. F2 · security: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F1 · shares: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21. F2 · shares: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F1 · derivative.exercise_date: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21. F3 · derivative.expiration_date: N/A Read SEC document |
| April 03, 2020 Filed Apr 7, 2020 21:29 UTC |
Mazzo David JDirector
|
GrantRestricted Stock Units · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-20-002462 · ownership.xml · derivative · entry 1 Mazzo David J · CIK 0001334549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires not disclosed F1 · security: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21. F2 · security: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F1 · shares: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21. F2 · shares: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F1 · derivative.exercise_date: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21. F3 · derivative.expiration_date: N/A Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 21:36 UTC |
SMITH SANDFORD DDirector
|
GrantCommon Stock | 166,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-19-004419 · ownership.xml · nonDerivative · entry 1 SMITH SANDFORD D · CIK 0001243004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,916 F1 · security: The shares represented are restricted stock grants pursuant to 50% of compensatory Annual Grant for director services equal to $50,0000. The shares vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/2020. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 21:35 UTC |
OGILVIE SCOTT VARDEDirector
|
GrantCommon Stock Purchase Option · Derivative | 187,510 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001171843-19-004417 · ownership.xml · derivative · entry 1 OGILVIE SCOTT VARDE · CIK 0001379413 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,510 Underlying: Common Stock · 187,510 shares Expires 2029-07-01 F1 · security: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20. F1 · derivative.exercise_date: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 21:35 UTC |
OLDAKER WILLIAM CLYDEDirector
|
GrantCommon Stock Purchase Option · Derivative | 187,510 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001171843-19-004418 · ownership.xml · derivative · entry 1 OLDAKER WILLIAM CLYDE · CIK 0001397571 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,510 Underlying: Common Stock · 187,510 shares Expires 2029-07-01 F1 · security: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20. F1 · derivative.exercise_date: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 21:34 UTC |
Mazzo David JDirector
|
GrantCommon Stock Purchase Option · Derivative | 187,510 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001171843-19-004416 · ownership.xml · derivative · entry 1 Mazzo David J · CIK 0001334549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,510 Underlying: Common Stock · 187,510 shares Expires 2029-07-01 F1 · security: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20. F1 · derivative.exercise_date: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 21:33 UTC |
Csimma CristinaDirector
|
GrantCommon Stock Purchase Option · Derivative | 187,510 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001171843-19-004415 · ownership.xml · derivative · entry 1 Csimma Cristina · CIK 0001501623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,510 Underlying: Common Stock · 187,510 shares Expires 2029-07-01 F1 · security: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20. F1 · derivative.exercise_date: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20. Read SEC document |
| July 01, 2019 Filed Oct 11, 2019 23:23 UTC Amendment |
OGILVIE SCOTT VARDEDirector
|
GrantCommon Stock Purchase Option · Derivative | 10,106 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001171843-19-006480 · ownership.xml · derivative · entry 1 OGILVIE SCOTT VARDE · CIK 0001379413 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,106 Underlying: Common Stock · 10,106 shares Expires 2029-07-01 F1 · security: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20. F3 · security: This amendment is being filed to correct a scrivener's error with regard to the option amount previously reported. F2 · derivative.exercise_price: All exercise prices and share amounts reported in this Form 4/A reflect a 1-for-20 reverse split that occurred on July 17, 2019. F2 · shares: All exercise prices and share amounts reported in this Form 4/A reflect a 1-for-20 reverse split that occurred on July 17, 2019. F3 · shares: This amendment is being filed to correct a scrivener's error with regard to the option amount previously reported. F1 · derivative.exercise_date: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20. Read SEC document |
| July 01, 2019 Filed Oct 11, 2019 23:25 UTC Amendment |
Csimma CristinaDirector
|
GrantCommon Stock Purchase Option · Derivative | 10,106 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001171843-19-006481 · ownership.xml · derivative · entry 1 Csimma Cristina · CIK 0001501623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,106 Underlying: Common Stock · 10,106 shares Expires 2029-07-01 F1 · security: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20. F3 · security: This amendment is being filed to correct a scrivener's error with regard to the option amount previously reported. F2 · derivative.exercise_price: All exercise prices and share amounts reported in this Form 4/A reflect a 1-for-20 reverse split that occurred on July 17, 2019. F2 · shares: All exercise prices and share amounts reported in this Form 4/A reflect a 1-for-20 reverse split that occurred on July 17, 2019. F3 · shares: This amendment is being filed to correct a scrivener's error with regard to the option amount previously reported. F1 · derivative.exercise_date: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20. Read SEC document |
| July 01, 2019 Filed Oct 11, 2019 23:27 UTC Amendment |
Mazzo David JDirector
|
GrantCommon Stock Purchase Option · Derivative | 10,106 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001171843-19-006482 · ownership.xml · derivative · entry 1 Mazzo David J · CIK 0001334549 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,106 Underlying: Common Stock · 10,106 shares Expires 2029-07-01 F1 · security: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20. F3 · security: This amendment is being filed to correct a scrivener's error with regard to the option amount previously reported. F2 · derivative.exercise_price: All exercise prices and share amounts reported in this Form 4/A reflect a 1-for-20 reverse split that occurred on July 17, 2019. F2 · shares: All exercise prices and share amounts reported in this Form 4/A reflect a 1-for-20 reverse split that occurred on July 17, 2019. F3 · shares: This amendment is being filed to correct a scrivener's error with regard to the option amount previously reported. F1 · derivative.exercise_date: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 20:51 UTC |
WESTREICH STANLEYDirector
|
GrantCommon Stock Purchase Option · Derivative | 59,660 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0001171843-18-005068 · formfour.xml · derivative · entry 1 WESTREICH STANLEY · CIK 0001238046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,660 Underlying: Common Stock · 59,660 shares Expires 2028-07-02 F1 · security: Represents 50% of compensatory Annual Grant for director services of $100,000. The options vest quarterly on 9/30/18, 12/31/18, 3/31/19, and 6/30/19. F1 · derivative.exercise_date: Represents 50% of compensatory Annual Grant for director services of $100,000. The options vest quarterly on 9/30/18, 12/31/18, 3/31/19, and 6/30/19. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 20:50 UTC |
Csimma CristinaDirector
|
GrantCommon Stock Purchase Option · Derivative | 59,660 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0001171843-18-005067 · formfour.xml · derivative · entry 1 Csimma Cristina · CIK 0001501623 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,660 Underlying: Common Stock · 59,660 shares Expires 2028-07-02 F1 · security: Represents 50% of compensatory Annual Grant for director services of $100,000. The options vest quarterly on 9/30/18, 12/31/18, 3/31/19, and 6/30/19. F1 · derivative.exercise_date: Represents 50% of compensatory Annual Grant for director services of $100,000. The options vest quarterly on 9/30/18, 12/31/18, 3/31/19, and 6/30/19. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 20:32 UTC |
OGILVIE SCOTT VARDEDirector
|
GrantCommon Stock Purchase Option · Derivative | 59,660 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0001171843-18-005065 · formfour.xml · derivative · entry 1 OGILVIE SCOTT VARDE · CIK 0001379413 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,660 Underlying: Common Stock · 59,660 shares Expires 2028-07-02 F1 · security: Represents 50% of compensatory Annual Grant for director services of $100,000. The options vest quarterly on 9/30/18, 12/31/18, 3/31/19, and 6/30/19. F1 · derivative.exercise_date: Represents 50% of compensatory Annual Grant for director services of $100,000. The options vest quarterly on 9/30/18, 12/31/18, 3/31/19, and 6/30/19. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 20:31 UTC |
OLDAKER WILLIAM CLYDEDirector
|
GrantCommon Stock Purchase Option · Derivative | 59,660 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0001171843-18-005064 · formfour.xml · derivative · entry 1 OLDAKER WILLIAM CLYDE · CIK 0001397571 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,660 Underlying: Common Stock · 59,660 shares Expires 2028-07-02 F1 · security: Represents 50% of compensatory Annual Grant for director services of $100,000. The options vest quarterly on 9/30/18, 12/31/18, 3/31/19, and 6/30/19. F1 · derivative.exercise_date: Represents 50% of compensatory Annual Grant for director services of $100,000. The options vest quarterly on 9/30/18, 12/31/18, 3/31/19, and 6/30/19. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 20:30 UTC |
SMITH SANDFORD DDirector
|
GrantCommon Stock | 45,046 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-18-005063 · formfour.xml · nonDerivative · entry 1 SMITH SANDFORD D · CIK 0001243004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,899 F1 · security: The shares represented are restricted stock grants pursuant to 50% of compensatory Annual Grant for director services of $100,000. The shares vest quarterly on 9/30/18, 12/31/18, 3/31/19, and 6/30/2019. Read SEC document |
| November 07, 2017 Filed Nov 9, 2017 21:00 UTC |
Daly Richard JDirector · Chief Executive Officer
|
GrantCommon Stock Purchase Option · Derivative | 100,000 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001171843-17-006832 · formfour.xml · derivative · entry 1 Daly Richard J · CIK 0001635393 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2027-11-07 F1 · security: Represents a discretionary grant to Employee. The options vest quarterly on 2/718, 5/7/18, 8/7/18, and 11/7/18. Read SEC document |
| July 14, 2017 Filed Jul 18, 2017 20:32 UTC |
WESTREICH STANLEYDirector
|
GrantCommon Stock | 18,622 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-17-004171 · formfour.xml · nonDerivative · entry 1 WESTREICH STANLEY · CIK 0001238046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,281 F1 · security: The shares represented are restricted stock grants pursuant to compensatory Annual Grant for director services of $100,000. The shares vest quarterly on 9/30/17, 12/31/17, 3/31/18, and 6/30/2018. Read SEC document |
| July 14, 2017 Filed Jul 18, 2017 20:32 UTC |
SMITH SANDFORD DDirector
|
GrantRestricted Stock Units · Derivative | 9,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-17-004170 · formfour.xml · derivative · entry 1 SMITH SANDFORD D · CIK 0001243004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,311 Underlying: Common Stock · 9,311 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · shares: Represents 50% of compensatory Annual Grant for director services of $100,000. The RSU's vest quarterly on 9/30/17, 12/31/17, 3/31/18, and 6/30/18. F2 · derivative.exercise_date: Represents 50% of compensatory Annual Grant for director services of $100,000. The RSU's vest quarterly on 9/30/17, 12/31/17, 3/31/18, and 6/30/18. F2 · derivative.expiration_date: Represents 50% of compensatory Annual Grant for director services of $100,000. The RSU's vest quarterly on 9/30/17, 12/31/17, 3/31/18, and 6/30/18. Read SEC document |
| July 14, 2017 Filed Jul 18, 2017 20:31 UTC |
OLDAKER WILLIAM CLYDEDirector
|
GrantCommon Stock | 18,622 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-17-004169 · formfour.xml · nonDerivative · entry 1 OLDAKER WILLIAM CLYDE · CIK 0001397571 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,763 F1 · security: The shares represented are restricted stock grants pursuant to compensatory Annual Grant for director services of $100,000. The shares vest quarterly on 9/30/17, 12/31/17, 3/31/18, and 6/30/2018. Read SEC document |
| July 14, 2017 Filed Jul 18, 2017 20:30 UTC |
OGILVIE SCOTT VARDEDirector
|
GrantCommon Stock Purchase Option · Derivative | 13,574 | $0.00 Strike: $5.37 | $0.00 |
DisclosureSEC source: 0001171843-17-004168 · formfour.xml · derivative · entry 1 OGILVIE SCOTT VARDE · CIK 0001379413 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,574 Underlying: Common Stock · 13,574 shares Expires 2027-07-14 F1 · security: Represents 50% of compensatory Annual Grant for director services of $100,000. The options vest quarterly on 9/30/17, 12/31/17, 3/31/18, and 6/30/18. F1 · derivative.exercise_date: Represents 50% of compensatory Annual Grant for director services of $100,000. The options vest quarterly on 9/30/17, 12/31/17, 3/31/18, and 6/30/18. Read SEC document |
| May 17, 2017 Filed May 18, 2017 17:02 UTC |
Daly Richard JDirector · Chief Executive Officer
|
PurchaseCommon Stock | 7,500 | $4.00 | $30,000.00 |
DisclosureSEC source: 0001171843-17-003169 · formfour.xml · nonDerivative · entry 1 Daly Richard J · CIK 0001635393 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,312 F1 · security: Reporting person, Richard Daly, purchased 7,500 shares of common stock in a private transaction directly from the issuer on May 17, 2017. Read SEC document |
| April 11, 2017 Filed Apr 13, 2017 20:20 UTC |
WESTREICH STANLEYDirector
|
GrantCommon Stock Purchase Option · Derivative | 33,408 | $0.00 Strike: $4.96 | $0.00 |
DisclosureSEC source: 0001171843-17-002114 · f4_westreich041317.xml · derivative · entry 1 WESTREICH STANLEY · CIK 0001238046 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,408 Underlying: Common Stock · 33,408 shares Expires 2024-04-11 F1 · security: On April 11, 2017, Neuralstem issued a conditional grant to reporting person for services rendered as a director for the 2016 fiscal board year. The grant is 100% vested on the grant date and is being made on a conditional basis pursuant to NASDAQ market rules and will not be exercisable and will be subject to forfeiture if applicable shareholder approval is not received. F1 · derivative.exercise_date: On April 11, 2017, Neuralstem issued a conditional grant to reporting person for services rendered as a director for the 2016 fiscal board year. The grant is 100% vested on the grant date and is being made on a conditional basis pursuant to NASDAQ market rules and will not be exercisable and will be subject to forfeiture if applicable shareholder approval is not received. Read SEC document |
| March 24, 2017 Filed Mar 27, 2017 20:06 UTC |
LLOYD JONES JONATHAN BRIANChief Financial Officer
|
PurchaseCommon Stock | 5,455 | $5.50 | $30,002.50 |
DisclosureSEC source: 0001171843-17-001771 · formfour.xml · nonDerivative · entry 1 LLOYD JONES JONATHAN BRIAN · CIK 0001567657 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,859 F1 · security: Reporting person, Jonathan Lloyd Jones, purchased 5,455 shares of common stock in a private transaction directly from the issuer. Read SEC document |
| February 24, 2017 Filed Feb 27, 2017 21:30 UTC |
Daly Richard JDirector · Chief Executive Officer
|
PurchaseCommon Stock | 2,591 | $3.86 | $10,001.26 |
DisclosureSEC source: 0001171843-17-001161 · form4.xml · nonDerivative · entry 1 Daly Richard J · CIK 0001635393 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,812 F1 · security: Reporting person, Richard Daly, purchased 2,591 shares of common stock in a private transaction directly from the issuer. Read SEC document |
| January 25, 2017 Filed Jan 27, 2017 21:18 UTC |
Daly Richard JDirector · Chief Executive Officer
|
PurchaseCommon Stock | 2,841 | $3.52 | $10,000.32 |
DisclosureSEC source: 0001171843-17-000498 · form4daly.xml · nonDerivative · entry 1 Daly Richard J · CIK 0001635393 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,221 F1 · security: Reporting person, Richard Daly, purchased 2,841 shares of common stock in a private transaction directly from the issuer. Read SEC document |
| December 23, 2016 Filed Dec 30, 2016 21:05 UTC |
Daly Richard JDirector · Chief Executive Officer
|
PurchaseCommon Stock | 32,259 | $0.31 | $10,000.29 |
DisclosureSEC source: 0001171843-16-013813 · formfour.xml · nonDerivative · entry 1 Daly Richard J · CIK 0001635393 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,939 F1 · security: Reporting person, Richard Daly, purchased 32,259 shares of common stock in a private transaction directly from the issuer. Read SEC document |
| November 25, 2016 Filed Nov 28, 2016 22:36 UTC |
Daly Richard JDirector · Chief Executive Officer
|
PurchaseCommon Stock | 35,715 | $0.28 | $10,000.20 |
DisclosureSEC source: 0001171843-16-013393 · formfour.xml · nonDerivative · entry 1 Daly Richard J · CIK 0001635393 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,680 F1 · security: Reporting person, Richard Daly, purchased 35,715 shares of common stock in a private transaction directly from the issuer. Read SEC document |
| October 25, 2016 Filed Oct 27, 2016 20:05 UTC |
Daly Richard JDirector · Chief Executive Officer
|
PurchaseCommon Stock | 35,715 | $0.28 | $10,000.20 |
DisclosureSEC source: 0001171843-16-012678 · formfour.xml · nonDerivative · entry 1 Daly Richard J · CIK 0001635393 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,965 F1 · security: Reporting person, Richard Daly, purchased 35,715 shares of common stock in a private transaction directly from the issuer. Read SEC document |
| September 23, 2016 Filed Sep 26, 2016 20:51 UTC |
LLOYD JONES JONATHAN BRIANChief Financial Officer
|
PurchaseCommon Stock | 31,250 | $0.32 | $10,000.00 |
DisclosureSEC source: 0001171843-16-012275 · formfour.xml · nonDerivative · entry 1 LLOYD JONES JONATHAN BRIAN · CIK 0001567657 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,250 F1 · security: Reporting person, Jonathan Lloyd Jones, purchased 31,250 shares of common stock in a private transaction directly from the issuer. Read SEC document |
| September 23, 2016 Filed Sep 26, 2016 20:50 UTC |
Daly Richard JDirector · Chief Executive Officer
|
PurchaseCommon Stock | 31,250 | $0.32 | $10,000.00 |
DisclosureSEC source: 0001171843-16-012274 · f4_092616daly.xml · nonDerivative · entry 1 Daly Richard J · CIK 0001635393 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,250 F1 · security: Reporting person, Richard Daly, purchased 31,250 shares of common stock in a private transaction directly from the issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.